A Multigene Assay Is Prognostic of Survival in Patients With Early-Stage Lung Adenocarcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-0544
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Classification and Survival Prediction for Early‑stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients

Oncology Letters
Cancer ResearchOncology
2017English

Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated With Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

SCD1 Is Associated With Tumor Promotion, Late Stage and Poor Survival in Lung Adenocarcinoma

Oncotarget
Oncology
2016English

Molecular Prognostic Factors in Early-Stage Cervical Adenocarcinoma

Polish Journal of Pathology
MedicineForensic MedicinePathology
2018English

DNA Hypomethylation-Related Overexpression of SFN, GORASP2 and ZYG11A Is a Novel Prognostic Biomarker for Early Stage Lung Adenocarcinoma

Oncotarget
Oncology
2019English

Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients With Lung Adenocarcinoma

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

High Expression of SLC34A2 Is a Favorable Prognostic Marker in Lung Adenocarcinoma Patients

Tumor Biology
MedicineCancer Research
2017English

Age Is a Prognostic Factor Affecting Survival in Lung Cancer Patients

Oncology Letters
Cancer ResearchOncology
2013English

Increased CX3CL1 mRNA Expression Level Is a Positive Prognostic Factor in Patients With Lung Adenocarcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy